Indication of metronomic chemotherapy for metastatic breast cancer: Clinical outcomes and responsive subtypes

The survival of patients with metastatic breast cancer (MBC) has not improved, despite recent advances in therapeutic strategies. This is mainly due to the fact that cytotoxic agents cannot be administered over a long period, even if they exhibit favorable activity, due to treatment-related side eff...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mol Clin Oncol
Main Authors: KONTANI, KEIICHI, HASHIMOTO, SHIN-ICHIRO, MURAZAWA, CHISA, NORIMURA, SHOKO, TANAKA, HIROAKI, OHTANI, MASAHIRO, FUJIWARA-HONJO, NAOMI, DATE, MANABU, TERAMOTO, KOJI, HOUCHI, HITOSHI, YOKOMISE, HIROYASU
Format: Artigo
Sprog:Inglês
Udgivet: D.A. Spandidos 2016
Fag:
Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4887815/
https://ncbi.nlm.nih.gov/pubmed/27284428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2016.841
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker